FOX RUN MANAGEMENT, L.L.C. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 268 filers reported holding HAEMONETICS CORP in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
FOX RUN MANAGEMENT, L.L.C. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$1,194,514
+20.7%
14,030
+11.5%
0.34%
-15.4%
Q4 2022$989,574
+371.2%
12,582
+566.1%
0.40%
+4.7%
Q1 2021$210,000
-71.6%
1,889
-70.7%
0.38%
-36.4%
Q4 2019$740,000
+80.5%
6,441
+40.8%
0.60%
+358.5%
Q2 2018$410,000
+78.3%
4,573
+45.5%
0.13%
+132.1%
Q1 2018$230,000
-39.9%
3,142
-67.6%
0.06%
-57.6%
Q2 2017$383,000
+60.9%
9,700
+18.3%
0.13%
+13.8%
Q2 2016$238,000
-13.8%
8,200
+3.8%
0.12%
-37.0%
Q1 2016$276,0007,9000.18%
Other shareholders
HAEMONETICS CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders